07:00 , Mar 28, 2013 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Colorectal cancer Epiregulin (EREG) In vitro and mouse studies suggest inhibiting EREG could help treat colitis-associated colorectal cancer. EREG expression was upregulated in tumor tissues...
08:00 , Feb 5, 2009 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

This week in therapeutics Indication Target/ marker/ pathway Summary Licensing status Publication and contact information Cancer Breast cancer Cyclin D1 (CCND1; BCL1); epiregulin (EREG); cyclin-dependent kinase inhibitor 1B (CDKN1B; p27; Kip1); epidermal growth factor receptor...